Search results for "Solid"

showing 10 items of 3575 documents

Concentrations of  9-Tetrahydrocannabinol and 11-Nor-9-Carboxytetrahydrocannabinol in Blood and Urine After Passive Exposure to Cannabis Smoke in a C…

2010

Cannabinoid concentrations in blood and urine after passive exposure to cannabis smoke under real-life conditions were investigated in this study. Eight healthy volunteers were exposed to cannabis smoke for 3 h in a well-attended coffee shop in Maastricht, Netherlands. An initial blood and urine sample was taken from each volunteer before exposure. Blood samples were taken 1.5, 3.5, 6, and 14 h after start of initial exposure, and urine samples were taken after 3.5, 6, 14, 36, 60, and 84 h. The samples were subjected to immunoassay screening for cannabinoids and analyzed using gas chromatography-mass spectrometry (GC-MS) for Delta(9)-tetrahydrocannabinol (THC), 11-nor-hydroxy-Delta(9)-tetra…

AdultMaleTime FactorsHealth Toxicology and Mutagenesismedicine.medical_treatmentEnzyme-Linked Immunosorbent AssayUrineToxicologyGas Chromatography-Mass SpectrometryAnalytical ChemistryPharmacokineticsLimit of DetectionSmokemental disordersmedicineHumansEnvironmental ChemistryDronabinolSolid phase extractionVolunteerCannabisNetherlandsInhalation exposureInhalation ExposureChemical Health and SafetyChromatographymedicine.diagnostic_testChemistryorganic chemicalsReproducibility of ResultsMiddle AgedAir Pollution IndoorImmunoassayFemaleCannabinoidGas chromatography–mass spectrometryJournal of Analytical Toxicology
researchProduct

Hamartoma of the urinary bladder: case report and review of the literature.

1999

Bladder hamartoma is a rare benign entity with only eight cases reported in the literature thus far, and whose general imaging features have not, to our knowledge, been previously discussed. The purpose of this report is to review the literature and to discuss the imaging findings in one case of bladder hamartoma where US features were those of an inhomogeneous solid mass with an unechogenic center, which was in accordance with the CT findings of a soft tissue mass with central inhomogeneous enhancement due to central necrosis.

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesPathologymedicine.medical_specialtyHamartomaUrinary BladderCentral necrosisCystectomyDiagnosis DifferentialMedicineSoft tissue massHamartomaHumansRadiology Nuclear Medicine and imagingCt findingsNeuroradiologyUltrasonographyUrinary bladdermedicine.diagnostic_testbusiness.industryUrinary Bladder DiseasesSolid massInterventional radiologyGeneral Medicinemedicine.diseasemedicine.anatomical_structureRadiologybusinessTomography X-Ray ComputedEuropean radiology
researchProduct

The Bandwidth of VWM Consolidation Varies With the Stimulus Feature: Evidence From Event-Related Potentials

2018

Our previous work suggests that 2 colors can be consolidated into visual short-term memory (VSTM) in parallel without a loss of memory precision, whereas consolidation of 2 orientations is performed in a strictly serial manner. Those experiments compared VSTM performance for simultaneously and sequentially presented stimuli. However, there is still controversy about whether the bandwidth for consolidation is determined by the type of information. To further investigate this issue, here we measured electroencephalography while participants attempted to consolidate 1, 2 or 4 simultaneously presented colors (Experiment 1) or orientations (Experiment 2) under limited presentation times. We used…

AdultMalemedicine.medical_specialtyComputer scienceShort-term memoryExperimental and Cognitive PsychologyAudiologyStimulus (physiology)Electroencephalographynäkömuistita3112050105 experimental psychologyArticleworking memorystimuli03 medical and health sciencesBehavioral NeuroscienceYoung Adult0302 clinical medicineArts and Humanities (miscellaneous)Visual memoryEvent-related potentialmedicineHumans0501 psychology and cognitive sciencesVisual short-term memoryEEGEvoked Potentialsta515Memory ConsolidationCerebral Cortexmedicine.diagnostic_testArabidopsis Proteins05 social sciencesNuclear ProteinsElectroencephalographytyömuistiElectrophysiologyMemory Short-TermVisual PerceptionMemory consolidationFemalevisual memory030217 neurology & neurosurgeryPsychomotor Performanceärsykkeet
researchProduct

Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.

2017

Summary We assessed the safety and efficacy of bortezomib, cyclophosphamide and dexamethasone (VCD) induction therapy in previously untreated multiple myeloma patients. A total of 414 patients received three 21-day cycles of VCD prior to autologous stem-cell transplantation (ASCT). Most common grade ≥3 adverse events were leucopenia (31·4%) and thrombocytopenia (6·8%). The overall response rate (ORR) by investigator-based assessment was 85·4%. Most patients (74%) underwent successful central laboratory-based molecular cytogenetic analysis. No clinically relevant differences in ORR post-induction were seen between patients with or without high-risk cytogenetic abnormalities (86·2% vs. 84·3%)…

AdultMalemedicine.medical_specialtyCyclophosphamideAdolescentPhases of clinical researchGastroenterologyRisk AssessmentTransplantation AutologousDexamethasoneBortezomib03 medical and health sciencesCytogeneticsYoung Adult0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAdverse effectCyclophosphamideMultiple myelomaDexamethasoneBortezomibbusiness.industryHematologyInduction ChemotherapyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryTransplantationConsolidation ChemotherapyRegimen030220 oncology & carcinogenesisFemalebusinessMultiple Myeloma030215 immunologymedicine.drugStem Cell TransplantationBritish journal of haematology
researchProduct

Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leu…

2015

Outcome of patients with primary refractory acute myeloid leukemia remains unsatisfactory. We conducted a prospective phase II clinical trial with gemtuzumab ozogamicin (3 mg/m(2) intravenously on day 1), all-trans retinoic acid (45 mg/m(2) orally on days 4-6 and 15 mg/m(2) orally on days 7-28), high-dose cytarabine (3 g/m(2)/12 h intravenously on days 1-3) and mitoxantrone (12 mg/m(2) intravenously on days 2-3) in 93 patients aged 18-60 years refractory to one cycle of induction therapy. Primary end point of the study was response to therapy; secondary end points included evaluation of toxicities, in particular, rate of sinusoidal obstruction syndrome after allogeneic hematopoietic cell tr…

AdultMalemedicine.medical_specialtyGemtuzumab ozogamicinmedicine.medical_treatmentSalvage therapyTretinoinComorbidityKaplan-Meier EstimateAntibodies Monoclonal HumanizedGastroenterology03 medical and health sciencesYoung Adult0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansSalvage TherapyMitoxantroneChemotherapybusiness.industryRemission InductionCytarabineHematopoietic Stem Cell TransplantationMyeloid leukemiaHematologyArticlesMiddle Agedmedicine.diseaseGemtuzumab3. Good healthSurgeryTransplantationConsolidation ChemotherapyLeukemiaLeukemia Myeloid AcuteAminoglycosidesTreatment Outcome030220 oncology & carcinogenesisCytarabineFemaleMitoxantronebusiness030215 immunologymedicine.drugHaematologica
researchProduct

Recurrence rate of oral squamous cell papilloma after excision with surgical scalpel or laser therapy : a retrospective cohort study

2019

Background The aim was to describe the recurrence rates of Oral Squamous Cell Papilloma (OSCP) following surgical treatment with surgical scalpel and two different lasers (CO2 or Er,Cr;YSGG) and to determine the clinical and histopathologic features of these lesions. Material and Methods A retrospective cohort study covering a period of 12 years (1997-2009) that included patients diagnosed of OSCP treated with surgical excision was performed. Data was processed using SPSS 22.0 (SPPS Inc. Chicago, USA) and a descriptive and bivariate analysis were conducted. Results A total of 37 histopathologically confirmed OSCP in 36 patients, 19 women (52.7%) and 17 men (47.2%) with an average age of 33.…

AdultMalemedicine.medical_specialtyPapillomavirusesLasers Solid-State03 medical and health sciences0302 clinical medicineOral surgeryLaser therapyTonguemedicineHumansIn patientSurgical treatmentPapil·lomavirusGeneral DentistryRetrospective StudiesOral Medicine and PathologyCo2 laserCirurgia oralbusiness.industryResearchEpithelial CellsMean ageRetrospective cohort study030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Surgerymedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSquamous cell papillomaFemaleSurgeryLaser TherapyNeoplasm Recurrence Localbusiness
researchProduct

Human infant saliva peptidome is modified with age and diet transition.

2012

Abstract In order to describe developmental changes in human salivary peptidome, whole saliva was obtained from 98 infants followed longitudinally at 3 and 6 months of age. Data on teeth eruption and diet at the age of 6 months were also recorded. Salivary peptide extracts were characterised by label-free MALDI-MS. Peptides differentially expressed between the two ages, and those significantly affected by teeth eruption or introduction of solid foods were identified by MALDI TOF–TOF and LC ESI MS–MS. Out of 81 peaks retained for statistical analysis, 26 were overexpressed at the age of 6 months. Exposure to solid foods had a more pronounced effect on profiles (overexpression of nine peaks) …

AdultMalemedicine.medical_specialtySalivaAgingProteomeBiophysicsBiology01 natural sciencesBiochemistryTooth Eruption03 medical and health sciencesstomatognathic systemInternal medicinemedicineHumansStatistical analysisWhole salivaSalivary Proteins and PeptidesSalivaComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesChromatographyTransition (genetics)010401 analytical chemistryInfantFeeding Behavior0104 chemical sciencesEndocrinologySolid foodHistatinSalivary ProteinsFemalePeptides[SDV.AEN]Life Sciences [q-bio]/Food and NutritionJournal of proteomics
researchProduct

Case series of 589 tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd: YAG low-level laser …

2013

Objective: Trauma during dental surgery is a predisposing factor for bisphosphonates (BP)-related osteonecrosis of the jaws (BRONJ). However, about 40% of cases of BRONJ are not related to dental invasive procedures, being probably associated to endodontic or periodontal infections. Extraction of non-treatable teeth is considered a reliable choice, to improve symptoms and to reduce the risk of BRONJ. Here we report our experience of tooth extractions in patients under oral or intravenous BP therapy. Study Design: Two-hundred and seventeen patients (38 males, 179 females; mean age 68.72 ± 11.26 years, range 30 to 83 years) under BP therapy received 589 tooth extractions at the Unit of Oral M…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentOsteoporosisAntibioticsDentistryOdontologíaLasers Solid-StatePostoperative ComplicationsClinical ProtocolsmedicineHumansLow-Level Light TherapyDental CareGeneral DentistryMultiple myelomaLow level laser therapyAgedAged 80 and overBisphosphonate-associated osteonecrosis of the jawDiphosphonatesbusiness.industryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludSurgerystomatognathic diseasesOtorhinolaryngologyRheumatoid arthritisDental surgeryTooth ExtractionUNESCO::CIENCIAS MÉDICASResearch-ArticleBisphosphonate-Associated Osteonecrosis of the JawFemaleSurgeryOral SurgerybusinessOral medicine
researchProduct

Effects of post-extinction l-DOPA administration on the spontaneous recovery and reinstatement of fear in a human fMRI study

2015

Relapse is a pertinent problem in the treatment of anxiety disorders. In the laboratory, relapse is modeled as return of conditioned fear responses after successful fear extinction and is explained by insufficient retrieval and/or expression of the fear-inhibitory extinction memory that is generated during extinction learning. We have shown in mice and humans that return of fear can be prevented by administration of a single dose of the dopamine precursor l-3,4-dihydroxyphenylalanine (l-DOPA) immediately after extinction. In mice, this effect could be attributed to an enhancement of extinction memory consolidation. In our human study, we could not exclude that l-DOPA might have acted by int…

AdultMalemedicine.medical_treatmentDopamine AgentsSpontaneous recoveryExposure therapyVentromedial prefrontal cortexAmygdalaFear-potentiated startleExtinction PsychologicalDevelopmental psychologyLevodopaRandom AllocationDouble-Blind MethodConditioning PsychologicalmedicineHumansPharmacology (medical)Fear conditioningBiological PsychiatryMemory ConsolidationPharmacologyFear processing in the brainBrain MappingPsychotropic DrugsBrainFearGalvanic Skin Responsesocial sciencesExtinction (psychology)Magnetic Resonance ImaginghumanitiesPsychiatry and Mental healthmedicine.anatomical_structureNeurologyVisual PerceptionNeurology (clinical)CuesPsychologyNeuroscienceEuropean Neuropsychopharmacology
researchProduct

Systemic Treatment in Advanced Phyllodes Tumor of the Breast: A Multi-institutional European Retrospective Case-series Analyses

2022

Abstract Background: We aimed at investigating outcome of systemic treatments in advanced breast PT. Methods: All cases of advanced breast PT treated with systemic treatments from 1999 to 2019, in one of the referral sarcoma centres involved in the study, were retrospectively reviewed. Results: 56 female patients were identified. Median age was 52 (range 25-76) years. Patients re-ceived a median number of 2 systemic treatments (range 1-4). Best responses according to RECIST were: 1 (3.7%) CR, 11 (40.7%) PR, 6 (22.2%) SD, 9 (33.3%) PD with anthracyclines plus ifosfamide (AI); 2 (16.7%) PR, 4 (33.3%) SD, 6 (50.0%) PD with anthracycline alone; 3 (18.8%) PR, 4 (25.0%) SD, 9 (56.3%) PD with high…

AdultOncologyCancer Researchmedicine.medical_specialtyAdvanced setting; Breast tumor; Chemotherapy; Phyllodes; SarcomaBreast tumorBreast NeoplasmsAdvanced settingInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansMedicineChemotherapyResponse Evaluation Criteria in Solid TumorsAgedRetrospective StudiesSeries (stratigraphy)business.industryPhyllodes tumorPhyllodesSarcomaMiddle Agedmedicine.diseaseOncologyFemalebusiness
researchProduct